• Octreotide-depo 30mg lyophilisate

Expiration date: 01/2025

Action:

somatostatinoma

Composition:

octreotide 30 mg

auxiliary substances: copolymer of DL-lactic and glycolic acids

D-mannitol

carboxymethylcellulose sodium salt

Polysorbate-80

the solvent in the vial: D-mannitol

water for injections

Indications:

Treatment of acromegaly

Treatment of endocrine tumors of the gastrointestinal tract and pancreas

Octreotide-depo
30mg
lyophilisate